KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $672.0 million.

  • Boston Scientific's Net Income towards Common Stockholders rose 1893.81% to $672.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 5639.5%. This contributed to the annual value of $2.9 billion for FY2025, which is 5639.5% up from last year.
  • Boston Scientific's Net Income towards Common Stockholders amounted to $672.0 million in Q4 2025, which was up 1893.81% from $755.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Net Income towards Common Stockholders high stood at $797.0 million for Q2 2025, and its period low was $80.0 million during Q4 2021.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $366.0 million (2021), whereas its average is $397.4 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 287272.73% in 2021, then plummeted by 7033.64% in 2022.
  • Quarter analysis of 5 years shows Boston Scientific's Net Income towards Common Stockholders stood at $80.0 million in 2021, then soared by 57.5% to $126.0 million in 2022, then skyrocketed by 300.79% to $505.0 million in 2023, then increased by 11.88% to $565.0 million in 2024, then rose by 18.94% to $672.0 million in 2025.
  • Its Net Income towards Common Stockholders stands at $672.0 million for Q4 2025, versus $755.0 million for Q3 2025 and $797.0 million for Q2 2025.